Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is considered incurable with currently available therap
making it an appealing target for both diagnosis and therapy. The advancement of next-generation technologies that can serve as quantitative imaging biomarkers for diagnostic and therapeutic monitoring of HER2-positive (HER2+) disease in breast cancer patients has been widely touted as an effective app...
Interestingly, like HER2, STARD3 overexpression is stable during the transition of in situ to invasive carcinomas. 3.4. Immunochemistry on Residual Disease We conducted an analysis on residual cancer after NST. Among the cohort, we had 56 patients with partial/absent pathological response. Five ...
Breast cancer is a frequent disease for which the discovery of markers that enable early detection or prognostic assessment remains challenging. Circular RNAs (circRNAs) are single-stranded structures in closed loops that are produced by backsplicing. CircRNA and messenger RNA (mRNA) are generated co...
Summarizing a vast body of literature without losing meaningful information is a huge task, but the field — and patients — can benefit from these projects.doi:10.1038/s41572-020-0167-zNadia HarbeckNature Reviews Disease Primers
- 《Nature Reviews Disease Primers》 被引量: 0发表: 2019年 Breast cancer. If generalizations can be drawn from these two sessions, we would suggest that evidence can be seen in support of certain principles for the chemotherapy o... AU Buzdar,GR Blumenschein - 《Cancer Treatment Reviews》...
Fatima Cardoso Nature Reviews Disease Primers Sep 2019 CAS-1 JCR-Q1 SCIE 1298 被引用 · 0 笔记 引用 Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3 Alexander RauWolfgang LiebOliver Seifert...Roland E. Kontermann Molecular ...
Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China, Tel +86-512-6588-3545, Email whe@suda.edu.cn; hongxusuda@outlook.com Objective: This cross-sectional study aimed to explore the association of overweight and inflammatory indicators with breast cancer risk in Chinese ...
The prognostic value of miR-30a was also examined by Zhang and colleagues [108] on a heterogeneous set of 96 patients with breast cancer. The authors attributed the tumor-suppressive nature of this miRNA to its ability to target MTDH, thereby suppressing breast tumor growth and metastasis. ...
The present invention provides methods for detecting a breast cancer based on detecting the level of any of a number of markers, wherein the level of the marker reflects the presence of breast cancer